Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 3721 AL 3735

Expanding PPMI through Remote Data Acquisition and Analysis: Early Success and Future Growth with myPPMI

Tanner CM, Stanley CE, Brown EG, Chahine LM, Weintraub D, Dobkin RD, Poewe W, Tolosa E, Marras C, Schade S, Chou KL, Pavese N, Coffey CS, Brumm MC, Kurth R, Noyce AJ, Gonzalez-Latapi P, Matthews-McGee A, Korell M, Meng C, Chen X, Racelo L, Ricci J, Fitzgerald C, Rigby NH, Battles JA, Carley JK, Singh Z, Kruchkow L, McMahon BA, Flagg E, Lemon LP, Talarico JM, Brodkin K, Destro C, Kuhl MM, Fabrizio K, Marek K, Tropea TF; Parkinson's Progression Markers Initiative.

Ann Neurol. 2026 Oct;100 Suppl 38:S80-S87. doi: 10.1002/ana.78245. Epub 2026 May 10.

Multifaceted performances of α-synuclein in health and neurological diseases

Wang M, Xu Y, Wang S, Liang J, Cui X, Zhang C, Yang J, Sun L, Jin M.

Neuroscience. 2026 Apr 16;600:153-162. doi: 10.1016/j.neuroscience.2026.02.031. Epub 2026 Feb 23.

Magnetic Field-Guided Magnetic Nanoparticles as Neurotherapeutics for Neurological Disorders and Glioblastoma

Chiang MC, Yang YP, Nicol CJB.

Life (Basel). 2026 Feb 9;16(2):293. doi: 10.3390/life16020293.

A Bioinformatic Analysis of BAG Protein Interactors and Pathways in Alzheimer's and Parkinson's Disease

Ramanan S, Johnson GVW.

J Mol Neurosci. 2026 Apr 2;76(2):57. doi: 10.1007/s12031-026-02514-z.

α-Synuclein Biomarkers for Parkinson's Disease

Lodge A, Agin-Liebes J.

Cold Spring Harb Perspect Med. 2026 Feb 2;16(2):a041944. doi: 10.1101/cshperspect.a041944.

Sex and gender-related differences in neurological diseases: current challenges and recommendations for clinical practice

Cicero CE, Angelini L, Abbadessa G, Bruno M, Fiume G, Nucera B, Ornello R, Arabia G, Giuliano L, Guarnieri B, Lugaresi A, Perani D, Sacco S, Tassorelli C, Nicoletti A, Pellecchia MT; SIN Gender Neurology Study Group and SinDem Sex and gender differences in dementia Study Group.

Neurol Sci. 2026 Jan 6;47(1):108. doi: 10.1007/s10072-025-08623-8.

Micro-nanoplastics and Parkinson's disease: evidence and perspectives

Lin L, Li J, Zhu S, Zhang Z, Li Z, Xu P, Guo W.

NPJ Parkinsons Dis. 2026 Jan 24;12(1):56. doi: 10.1038/s41531-026-01272-4.

Periodic limb movements in Parkinson's disease: a critical review of pathophysiology and a framework for clinical management

Yi S, Liu H, Hu X, Xu J, Zhang S, Zhang H, Wang Z, Han T, Kou L, Xia Y, Wang T, Lin Z, Xiong N.

NPJ Parkinsons Dis. 2026 Apr 15. doi: 10.1038/s41531-026-01356-1. Online ahead of print.

Alpha-synuclein seed amplification assays differentiate synucleinopathies

Dai W, Lin H, Mao H, Kuang Y, Xu P, Li H.

Expert Rev Mol Diagn. 2026 Mar;26(3):223-239. doi: 10.1080/14737159.2026.2663033. Epub 2026 Apr 22.

Dissecting Motor Domain Responses to Vibration Therapy in Parkinson's Disease: A Systematic Review and Meta-Regression Protocol

Park SR, Seo JW, Kim K, Chun JM, Seok JW, Kim JD.

Neurol Ther. 2026 Jun;15(3):951-963. doi: 10.1007/s40120-026-00922-2. Epub 2026 Mar 25.

Association between PTEN-induced kinase 1 (PINK1) rs3738136 polymorphism and Parkinson's disease: A meta-analytic study

Shibi Anilkumar A, Thomas SM, Veerabathiran R.

J Investig Med. 2026 Apr 27:10815589261448841. doi: 10.1177/10815589261448841. Online ahead of print.

Use of AR/VR for Treatment of Freezing of Gait (FoG) in Parkinson's Disease (PD)

Pokharel A, Tamrakar A, Chopra N.

J Clin Med. 2026 Mar 9;15(5):2076. doi: 10.3390/jcm15052076.

Research Progress on the Mechanism of Ginsenosides in the Treatment of Parkinson's Disease

Wang S, Chen Z, Tang H, Gong J, Xu K, Wang K.

Int J Mol Sci. 2026 May 19;27(10):4544. doi: 10.3390/ijms27104544.

Meta analysis of glucose metabolism across Alzheimer's, Parkinson's and ALS Reveals emergence of adaptive brain glucometabolic responses and associated neurological functional profiles

Raikes AC, Garza M, Murrell AN, Brinton RD.

medRxiv [Preprint]. 2026 Apr 8:2026.04.07.26350339. doi: 10.64898/2026.04.07.26350339.

Cytokine associated neuroinflammation in Parkinson's disease: Molecular pathways, therapeutic targets, and translational insights

Dhapola R, Kumari S, Sharma P, Paidlewar M, Vellingiri B, Medhi B, HariKrishnaReddy D.

Cytokine Growth Factor Rev. 2026 Apr;88:1-17. doi: 10.1016/j.cytogfr.2026.01.001. Epub 2026 Jan 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias